ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 129 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $60,000 | -18.9% | 42,408 | 0.0% | 0.08% | -19.6% |
| Q3 2016 | $74,000 | +1.4% | 42,408 | 0.0% | 0.10% | -7.3% |
| Q2 2016 | $73,000 | -13.1% | 42,408 | 0.0% | 0.11% | -9.1% |
| Q1 2016 | $84,000 | -22.9% | 42,408 | -25.2% | 0.12% | -12.9% |
| Q4 2015 | $109,000 | -0.9% | 56,665 | 0.0% | 0.14% | -1.4% |
| Q3 2015 | $110,000 | -58.3% | 56,665 | 0.0% | 0.14% | -53.0% |
| Q2 2015 | $264,000 | +6.5% | 56,665 | -0.2% | 0.30% | +11.5% |
| Q1 2015 | $248,000 | +26.5% | 56,775 | 0.0% | 0.27% | +31.2% |
| Q4 2014 | $196,000 | -17.6% | 56,775 | 0.0% | 0.20% | -19.0% |
| Q3 2014 | $238,000 | -28.7% | 56,775 | 0.0% | 0.25% | -15.1% |
| Q2 2014 | $334,000 | -7.0% | 56,775 | 0.0% | 0.30% | -5.1% |
| Q1 2014 | $359,000 | +7.5% | 56,775 | 0.0% | 0.31% | 0.0% |
| Q4 2013 | $334,000 | +11.7% | 56,775 | 0.0% | 0.31% | +16.7% |
| Q3 2013 | $299,000 | -37.4% | 56,775 | -8.1% | 0.27% | -44.4% |
| Q2 2013 | $478,000 | – | 61,775 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |